Samsung Medical Center
| 大韓民国 | トルコ | オーストリア | |
| 乳癌化学療法 | から $19,200 | から $1,200 | から $15,000 |
| 食道癌化学療法 | - | から $5,000 | から $12,000 |
| 食道摘出術 | - | から $23,400 | から $30,000 |
| 食道切除術 | から $43,000 | から $24,192 | - |
| 放射線治療 | - | から $7,000 | から $20,000 |
Bookimedは食道癌治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。食道癌治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。食道癌治療の旅路でお一人になることはありません。
South Korea reports a 45.7% overall 5-year survival rate for esophageal cancer. Success rates for localized stage I cancer reach 74.8%. These figures rank among the highest globally. Elite Seoul centers maintain operative mortality rates below 5% through high-volume specialization and advanced surgical technology.
Bookimed Expert Insight: Success rates in South Korea are tied to hospital volume. Elite centers like Asan Medical Center perform over 65,000 operations annually. This experience leads to better outcomes. Patients should prioritize clinics with integrated tumor boards. Specialists like Dr. Keun Chil Park at Samsung Medical Center provide multidisciplinary precision for complex cases.
Patient Consensus: Patients note that rapid diagnostic work-ups at large tertiary hospitals are life-changing. Practical concerns often focus on maintaining nutrition and swallowing ability during recovery.
Advanced esophageal cancer treatment in South Korea utilizes robotic-assisted surgery and proton therapy to target tumors precisely. Centers prioritize minimally invasive techniques like endoscopic submucosal dissection (ESD) for early-stage cases. JCI-accredited facilities integrate Novalis and IGRT systems for high-dose radiation while sparing adjacent heart and lung tissue.
Bookimed Expert Insight: Data shows a high concentration of advanced technology in Seoul, where major centers like Asan Medical Center perform over 65,000 operations annually. While basic radiation is common, advanced proton therapy is more specialized. Patients should focus on clinics like Samsung Medical Center that combine IGRT with Novalis systems for the most refined tumor targeting.
Patient Consensus: Patients note it is important to remember that minimally invasive robotic surgery still requires significant recovery time. Many emphasize that surgeon experience with high volumes is just as critical as the technology used.
Minimally invasive surgery is a primary option for early-stage esophageal cancer in South Korea. Surgeons utilize laparoscopic or robotic esophagectomy to remove tumors through small incisions. These techniques minimize blood loss and lung complications. Leading Seoul hospitals provide these procedures within JCI-accredited oncology departments.
Bookimed Expert Insight: South Korea occupies a unique leadership position in digestive tract oncology. While many countries focus on Western diseases, Korean centers like Asan Medical Center perform over 65,000 operations annually. This immense volume allows surgeons to master robotic esophagectomy faster than in lower-volume regions. This experience translates into higher precision when operating in the tight spaces of the chest cavity.
Patient Consensus: Patients note that while recovery is still demanding, the robotic approach helps them start walking earlier. They emphasize choosing high-volume centers to ensure the surgical team handles these complex procedures daily.
Korean oncology teams design esophageal cancer plans through mandatory multidisciplinary boards prioritizing regional squamous cell carcinoma. Specialists utilize high-definition endoscopy and 18F-FDG PET-CT for precise staging. Protocols emphasize tri-modality therapy. These include neoadjuvant chemoradiotherapy followed by robotic-assisted minimally invasive surgery at JCI-accredited tertiary centers.
Bookimed Expert Insight: Data from South Korea's top hospitals reveals a massive experience gap. Samsung Medical Center alone manages over 2,000,000 patients annually and performs 45,000+ operations. This extreme volume allows teams to specialize in rare sub-types of esophageal cancer. Patients can benefit from robotic surgical expertise that typically requires 1,000+ procedures to master.
Patient Consensus: Patients note that nutrition is managed as a vital part of treatment. Teams focus on weight maintenance and swallowing support immediately after diagnosis.
Locally advanced esophageal cancer has spread past the initial lining or into nearby lymph nodes but hasn't reached distant organs. South Korean centers manage these cases using aggressive multimodal strategies. Most protocols combine neoadjuvant chemoradiation and surgery to aim for complete tumor clearance.
Bookimed Expert Insight: Patient volume is a major quality signal in South Korea. Facilities like Seoul National University Hospital and Asan Medical Center handle over 1,500,000 cases annually. This massive volume allows surgeons to specialize in complex, locally advanced cases that may be declined elsewhere. Smaller centers often lack the multidisciplinary infrastructure needed for these high-risk procedures.
Patient Consensus: Patients note that maintaining diet and weight during treatment is the biggest hurdle. Many emphasize seeking evaluation at high-volume centers to ensure a personalized multimodal plan is followed.
Patients in the Republic of Korea typically begin esophageal cancer treatment within 1 to 4 weeks after staging. Leading centers like Samsung Medical Center prioritize rapid diagnostics using PET-CT and biopsy. Treatment initiation depends strictly on completing clinical staging and ensuring the patient is nutritionally stable.
Bookimed Expert Insight: South Korean oncology centers handle massive patient volumes, with Severance Hospital serving 1.6 million outpatients annually. This high throughput creates a highly efficient diagnostic loop. Our data shows that clinics like SNUH, which treats the president, often complete complex staging and histopathology in under 7 days. This speed is a major differentiator from Western systems where diagnostics alone can take weeks.
Patient Consensus: Patients note that the real wait often involves hospital scheduling and completing final lab work. Many emphasize starting nutritional support early to avoid delays if swallowing becomes too difficult before surgery.
Language barriers in South Korea are managed effectively through dedicated International Healthcare Centers at major hospitals. JCI-accredited facilities in Seoul provide professional medical interpreters and multilingual staff. These systems ensure clear communication for complex esophageal cancer treatments and surgical consent processes.
Bookimed Expert Insight: While many assume communication is the main hurdle, the true value lies in hospital digitalization. Seoul National University Hospital has used full digital records since 2004. This system allows doctors to share precise diagnostic data instantly. It reduces the need for verbal explanations of complex medical histories.
Patient Consensus: Patients note that while basic English works for navigation, a dedicated translator is vital for understanding recovery steps. They emphasize bringing printed symptom timelines to avoid confusion during busy rounds with the medical team.
South Korean hospitals treat oesophageal cancer using esophagectomy, robotic-assisted surgery, and specialised endoscopic techniques like ESD. Specialists at major Seoul centres often combine chemotherapy with radiation. This shrinks tumours before they perform minimally invasive surgery. This multidisciplinary approach means treatment plans remain tailored to the individual stage.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital maintain formal partnerships with top US institutions. One example is the Mayo Clinic. These links mean patients access global protocols and clinical drug trials locally. Clinics like Gangnam Severance provide free interpreters for treatments over A$6,100. This support is critical for complex oncology cases.
Patient Consensus: Patients note that combining chemotherapy with radiation is a standard first step for advanced cases in South Korea. They emphasise planning for feeding support and daily caregiving early. Recovery from major oesophagectomy requires significant physical help.
South Korean oncology centres offer immunotherapy and targeted therapy for oesophageal cancer. Specialist centres use immune checkpoint inhibitors like Nivolumab and Pembrolizumab for metastatic cases. These treatments often combine with chemotherapy to improve survival outcomes. Korea is a global leader in complex gastrointestinal cancer care.
Bookimed Expert Insight: Data shows Korean hospitals provide a unique safety net for Australians through sheer volume. Samsung Medical Center treats over 2 million patients annually. This massive case experience allows surgeons to perform organ-sparing robotic procedures. Smaller international centres rarely attempt them. Look for clinics like Severance Hospital. It partners with MD Anderson to access the latest clinical drug trials.
Patient Consensus: Patients in Korea note that pathology testing for HER2 and PD-L1 markers is essential. This testing is required to access these drugs. Experiences suggest that immunotherapy like Keytruda shows rapid results. However, treatment often continues every four weeks for advanced stages.
Oesophageal cancer surgery in South Korea is highly safe. The country reports a 74.8% five-year survival rate for localised cases. Leading centres like Samsung Medical Center and Asan Medical Center use robotic Da Vinci systems. These institutions maintain operative mortality rates below 5% for complex oesophagectomy procedures.
Bookimed Expert Insight: South Korean oncology centres operate at a massive scale compared to many Australian facilities. Samsung Medical Center serves 2 million outpatients annually and partners with the Mayo Clinic. This high volume allows surgeons to specialise deeply. Dr Choi Yong Soo at Samsung focuses specifically on oesophageal and thoracic procedures. For Australian patients, this means accessing teams who treat rare squamous cell carcinomas daily.
Patient Consensus: Patients note that while Korean hospitals have strong medical capabilities, the recovery takes months. Successful outcomes often depend on hiring paid caregivers. They provide post-operative support during the long hospital stay.
Korean hospitals treat oesophageal cancer with a multidisciplinary approach. This combines robotic oesophagectomy, endoscopic resection, and chemoradiotherapy. Specialists at centres like Samsung Medical Center and Severance Hospital often use da Vinci robotic systems. These allow high-precision surgery. Early-stage cases typically undergo endoscopic submucosal dissection to preserve the oesophagus.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital handle massive volumes, with Severance performing over 4,000 robotic surgeries annually. Our data shows these centres offer internal digital systems that share real-time scans. This allows Australian patients to receive accurate remote surgical planning before they even leave home.
Patient Consensus: Patients note that major Seoul hospitals provide fantastic care with highly coordinated testing. Many describe successful plans involving radiation to shrink tumours, followed by chemotherapy and surgery. They emphasise that hospitals always re-verify pathology slides from Australia upon arrival.
South Korea reports a 5-year relative survival rate of approximately 42% to 45.7% for oesophageal cancer. Early detection significantly improves these outcomes. Stage I cases show survival rates over 72%. Specialised centres in Seoul further reduce operative mortality to below 5% through high-volume surgical expertise.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital often treat over 1 million outpatients annually. This massive patient volume creates a unique pattern. Doctors like Dr Keun Chil Park and Dr Choi Yong Soo see many complex oesophageal cases. In a month, they see more than many regional specialists see in a year. This concentrated experience is likely the reason. South Korea's survival rates have improved from 14% to over 42% since the 1990s.
Patient Consensus: Patients emphasise that individual fitness and staging matter more than general statistics. Many in South Korea recommend early nutrition support like PEG tubes. These help maintain strength during intensive treatment.
Robotic and minimally invasive surgery for oesophageal cancer is widely available in South Korea. Major Seoul centres use the da Vinci robotic system for precise tumour removal. These techniques reduce recovery times and blood loss compared to traditional open surgery protocols.
Bookimed Expert Insight: Korean surgical culture prioritises extreme volume and digitisation as safety markers. For example, Samsung Medical Center manages 45,000+ operations annually. Patients should note: Korea University Anam Hospital is JCI-accredited for the fifth consecutive time. This demonstrates a rare long-term commitment to international safety standards. Many other global hubs lack this commitment.
Patient Consensus: Patients in the Republic of Korea advise asking surgeons about their robotic oesophagectomy case volume. They note that while robotics help, skill matters most. Hospitals may also switch to traditional surgery if complications occur.
South Korean medical centres treat early-stage esophageal cancer using organ-preserving techniques like endoscopic submucosal dissection (ESD). This allows specialists to remove superficial tumours through the throat without external incisions. For specific cases, definitive chemoradiotherapy or robotic-assisted thoracic surgery serves as a less invasive alternative to major open surgery.
Bookimed Expert Insight: South Korea's high volume of routine gastric screenings leads to earlier detection than in many Western countries. This massive caseload allows Seoul-based centres to maintain specialised teams for organ-preserving treatments. For example, Samsung Medical Center manages Asia's largest cancer centre with 17 disease-specific departments. Hospitals of this scale often have the specific imaging necessary to confirm if a tumour is flat enough for non-surgical chemoradiation.
Patient Consensus: Patients find that Korean hospitals offer highly efficient treatment plans where chemotherapy and radiation can often be coordinated around daily life. People note that seeking a second opinion on whether a lesion is superficial is vital for avoiding major surgery.
South Korean hospitals offer technologies including proton beam therapy, immunotherapy, and robotic-assisted surgery for oesophageal cancer. Major Seoul centres like Samsung Medical Center provide these treatments. Specialists use precise radiation and minimally invasive techniques. These target tumours and protect the heart and lungs.
Bookimed Expert Insight: South Korea specialises in high-volume oncology, with Samsung Medical Center alone performing over 45,000 surgeries annually. This massive case-load gives surgeons like Dr Choi Yong Soo extensive experience. They handle complex thoracic procedures. Australian patients benefit from this expertise. High-volume centres often report better outcomes for technically demanding oesophageal surgeries.
Patient Consensus: Patients note that major Seoul hospitals provide cancer care comparable to top Western facilities. They helpfully suggest bringing all pathology slides and scans. This can speed up the treatment process in Korea.
Specialists in Korea treat early-stage oesophageal cancer using endoscopic submucosal dissection or robotic surgery. These methods remove tumours while preserving the oesophagus. Korean centres report survival rates over 90% for stage 1 cases. Doctors often perform procedures within high-volume JCI-accredited facilities in Seoul.
Bookimed Expert Insight: High-volume Korean centres like Asan Medical Center specialise in squamous cell cases. These clinics perform thousands of endoscopic procedures annually. This volume leads to faster recovery times for international patients. Australian patients benefit from doctors who treat this specific cancer type daily.
Patient Consensus: Patients note that screening in Korea finds tumours very early. They appreciate the clear explanations from English-speaking staff about robotic surgery options. Many felt reassured by the modern facilities and the efficiency of the diagnostic tests.
Oesophageal cancer follow-up in South Korea involves intensive monitoring. This includes CT scans, PET-CT, and gastroscopy. Specialist teams at facilities like Samsung Medical Center coordinate care for five years. Patients receive tailored nutritional support and voice therapy. This helps manage side effects and maintain quality of life.
Bookimed Expert Insight: South Korean oncology centres offer massive scale. Samsung Medical Center performs over 45,000 surgeries annually. This high volume allows clinics to maintain specialised departments. For oesophageal cases, patients benefit from specific thoracic experts like Dr Choi Yong Soo. He focuses on minimally invasive techniques to aid faster recovery.
Patient Consensus: Patients find that recovery requires several months of hard work and regular clinic visits. They emphasise nutritional care as the most critical part of follow-up in South Korea. This includes managing feeding tubes and hydration.
Neoadjuvant treatment in Korea commonly involves chemoradiotherapy before surgery to shrink tumours and eliminate microscopic cancer cells. Specialists such as Dr Keun Chil Park at Samsung Medical Center use regimens like the CROSS protocol or 5-FU and cisplatin. This improves successful surgical resection rates for squamous cell carcinoma.
Bookimed Expert Insight: Korea's massive patient volumes create a data-driven approach to neoadjuvant care. Seoul National University Hospital alone treats 30,000 international patients annually. This high turnover means local oncologists have refined the timing between chemotherapy and surgery to an exact science. They often achieve better pathological response rates than smaller regional centres.
Patient Consensus: Patients note that pre-operative radiation significantly improves swallowing and comfort even before surgery. Many emphasise that initial scans might not show full shrinkage. Yet pathology often confirms the tumour was successfully eradicated by the treatment.
South Korea houses several major tertiary hospitals that perform around 900 oesophagectomies annually. Many facilities exist, but a small group of high-volume centres in Seoul handles nearly 70% of these complex surgeries. These institutions maintain success rates between 85% and 90% for early-stage cases.
Bookimed Expert Insight: Data shows a clear trend toward digital and robotic specialisation in Seoul. Seoul National University Bundang Hospital became the first fully digital hospital in Korea. Asan Medical Center performs the most surgeries overall. Samsung Medical Center attracts complex cases with Asia's largest dedicated cancer centre. Patients should prioritise these high-volume hubs. Their surgeons often manage thousands of gastrointestinal procedures annually.
Patient Consensus: Patients note that major Seoul hospitals like Asan and Severance are often crowded. They are the primary choice for serious gastric cancers. Practical advice includes contacting international clinics at these centres to compare appointment wait times and confirm English-speaking support is available.